Primary (genetic hyperlipidaemia) refers to inherited disorders characterised by elevated plasma lipid levels due to genetic mutations affecting lipid metabolism. It is clinically important because early identification enables targeted management to reduce cardiovascular risk. A key complication is premature atherosclerosis leading to coronary artery disease.